ストックスクリーナーアプリを入手
6.03
0.99%
-0.06
アフターアワーズ：
6.13
0.10
+1.66%
前日終値:
$6.09
開ける：
$6.27
24時間の取引高:
87,155
Relative Volume:
1.42
時価総額：
$523.87M
収益：
$196.47M
当期純損益:
$-132.90M
株価収益率:
-3.8741
EPS:
-1.5565
ネットキャッシュフロー:
$-97.72M
1週間 パフォーマンス:
-3.52%
1か月 パフォーマンス:
-43.17%
6か月 パフォーマンス:
-42.57%
1年 パフォーマンス:
-14.47%
1日の値動き範囲:
$6.00
$6.31
1週間の範囲:
$5.92
$6.4199
52週間の値動き範囲:
$5.4289
$12.25
Valneva Se Adr Stock (VALN) Company Profile
Compare VALN vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
VALN
Valneva Se Adr
|
6.03 | 529.08M | 196.47M | -132.90M | -97.72M | -1.5565 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Valneva Se Adr Stock (VALN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-08-19 | 再開されました | H.C. Wainwright | Buy |
| 2022-08-03 | 開始されました | H.C. Wainwright | Buy |
Valneva Se Adr (VALN) 最新ニュース
Valneva SE Under Investigation for Securities Fraud - Intellectia AI
VALN stock nosedives on mixed results from Lyme disease vaccine study - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valneva SEVALN - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
VLA.PA Technical Analysis | Trend, Signals & Chart Patterns | VALNEVA SE (EPA:VLA) - ChartMill
Valneva (NASDAQ:VALN) Shares Gap DownHere's Why - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Shareholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Valneva SE (VALN) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Valneva Faces Mounting Legal Pressure Following Clinical Trial Setback - AD HOC NEWS
2026-04-06 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Shareholders to Learn More About the Investigation | NDAQ:VALN | Press Release - Stockhouse
Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Valneva's Travel Vaccines: Strategic Pivot to Emerging Markets Drives Long-Term Investor Value in Bi - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Valneva SE (VALN) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Declaration of shares and voting rights of Valneva SE – March 2026 - GlobeNewswire Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Investors to Connect - ACCESS Newswire
Valneva (NASDAQ:VALN) Shares Gap UpShould You Buy? - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages Valneva SE (VALN) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Valneva (NASDAQ:VALN) Sees Large Volume IncreaseHere's Why - MarketBeat
Short Interest in Valneva SE Sponsored ADR (NASDAQ:VALN) Rises By 25.4% - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Valneva SE (VALN) And Encourages Stockholders to Connect - ACCESS Newswire
2026-03-27 | Valneva SE (VALN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation | NDAQ:VALN | Press Release - Stockhouse
VLA.PA Stock Price, Quote & Chart | VALNEVA SE (EPA:VLA) - ChartMill
Valneva, Venture Global And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Valneva SE – VALN - FinancialContent
VALN Stock Nosedives on Mixed Results From Lyme Disease Vaccine Study - Yahoo Finance
VALN Shares Plunge Following Uncertain Outcomes in Lyme Disease Vaccine Trial - Bitget
Jefferies reiterates Valneva stock Buy rating after Lyme trial data - Investing.com
HC Wainwright Has Positive Forecast for Valneva Q3 Earnings - MarketBeat
Valneva (NASDAQ:VALN) Shares Gap Down – Here’s Why - Defense World
FY2030 Earnings Forecast for Valneva Issued By HC Wainwright - Defense World
FY2030 Earnings Estimate for Valneva Issued By HC Wainwright - MarketBeat
Earnings call transcript: Valneva SE Q4 2025 sees EPS beat, stock rises - Investing.com Canada
[20-F] Valneva SE Files Annual R... | VALN SEC FilingForm 20-F - Stock Titan
Valneva SE earnings beat by $0.13, revenue topped estimates - Investing.com India
VALN Doses First Infant With Shigella Vaccine in Mid-Stage Study - MSN
Valneva (NASDAQ:VALN) Sees Unusually-High Trading VolumeTime to Buy? - MarketBeat
Valneva (NASDAQ:VALN) Trading Up 7.1%Here's What Happened - MarketBeat
Valneva Se Adr (VALN) 財務データ
収益
当期純利益
現金流量
EPS
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):